Skip to content

Bottomline | The worrisome case of Aurobindo Pharma

For equity investors, even a hint of suspect governance is a big red flag. It isn#39;t surprising, therefore, that the Aurobindo Pharma stock came under selling pressure on November 10 after it was reported that its Director, P Sarath Chandra Reddy, had been arrested by the Enforcement Directorate.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish